Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolines and their use as anticoagulant and antithrombotics

US7582666B2 · kind B2 · utility

Assignee

• Bayer Schering Pharma AG · DE

Inventors

• Alexander Straub · Wuppertal, DE
• Thomas Lampe · Mülheim an der Ruhr, DE
• Josef Pernerstorfer · Wuppertal, DE
• Elisabeth Perzborn · Wuppertal, DE
• Jens Pohlmann · Basel, CH
• Susanne Röhrig · Hilden, DE
• Karl-Heinz Schlemmer · Wuppertal, DE

Key dates

• Filing date: Mar 31, 2006
• Grant date: Sep 1, 2009
• Expiry date: Apr 6, 2026

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D413/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to the field of blood coagulation, more particularly, to novel compounds of general formula (I),to a method for producing the compounds and to their use as active ingredients in medicaments for the prevention and/or the treatment of diseases.